phl boss download free

YOUNGLIMWON SOFTLAB To Showcase Low-Code Application Development Platform Flextudio At CES 2025None

Increasing Automotive Demand: A Key Driver Transforming The Automotive Ethernet Market 2024Byfield scores in 200th career game as Kings hold off Kraken for 2-1 winTCU's TD barrage breaks open tight game vs. ArizonaHow to Watch Top 25 Women’s College Basketball Games – Friday, November 22

Dec 17 (Reuters) - Companies ranging from finance majors to Silicon Valley behemoths are pledging donations to Donald Trump 's inaugural fund as business leaders rush to ensure a favorable relationship with the U.S. president-elect after his November election win . Trump is set to take office in January and executives are hoping a positive rapport with his administration, such as the one Tesla boss Elon Musk has established , could mean notable benefits for their companies. Below is a list of companies that are contributing funds for Trump's inauguration for his second term in the White House. Uber Technologies (UBER.N) , opens new tab and its CEO Dara Khosrowshahi donated $1 million each, a company spokesperson told Reuters. Amazon (AMZN.O) , opens new tab is donating $1 million . The company will also air the inauguration event on its Prime Video service, an Amazon spokesperson said. Meta Platforms (META.O) , opens new tab has donated $1 million , a company spokesperson told Reuters. CEO Sam Altman is planning to make a personal donation of $1 million to the inaugural fund, an OpenAI spokesperson confirmed. "President Trump will lead our country into the age of AI, and I am eager to support his efforts to ensure America stays ahead," Altman said in a statement. Bank of America (BAC.N) , opens new tab , the second-largest U.S. lender, and investment bank Goldman Sachs (GS.N) , opens new tab plan to contribute to Trump's inaugural committees, but have yet to decide on the amount, spokespersons for each bank said. Sign up here. Reporting by Jaspreet Singh, Deborah Sophia and Harshita Mary Varghese in Bengaluru; Editing by Pooja Desai Our Standards: The Thomson Reuters Trust Principles. , opens new tabPercentages: FG .557, FT .625. 3-Point Goals: 15-28, .536 (Joshua 3-3, Marshall 3-5, Klaczek 2-3, Reddish 2-3, Strand 2-4, Topuz 2-5, Briggs 1-3, Langford 0-1, Taylor 0-1). Team Rebounds: 0. Team Turnovers: None. Blocked Shots: 2 (Adewale, Klaczek). Turnovers: 15 (Neely 3, Adnan 2, Klaczek 2, Strand 2, Taylor 2, Giralt, Joshua, Marshall, Topuz). Steals: 12 (Joshua 5, Langford 2, Marshall 2, Strand 2, Lindsey). Technical Fouls: None. Percentages: FG .340, FT .478. 3-Point Goals: 5-19, .263 (Alicea 2-3, Maldonado 2-6, Bargas 1-3, Pagan 0-1, Gonzalez 0-2, Saavedra 0-2, Uselis 0-2). Team Rebounds: 0. Team Turnovers: None. Blocked Shots: 1 (Uselis). Turnovers: 19 (Perez 5, Alicea 4, Uselis 3, Saavedra 2, Bargas, Gonzalez, Guilfu, Pagan, Zayas). Steals: 4 (Bargas 2, Perez, Uselis). Technical Fouls: None. A_20 (12,000).

Nippon Sheet Glass Company, Limited ( OTCMKTS:NPSGY – Get Free Report ) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 800 shares, an increase of 60.0% from the November 30th total of 500 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 8.0 days. Nippon Sheet Glass Stock Performance OTCMKTS:NPSGY opened at $2.00 on Friday. Nippon Sheet Glass has a one year low of $2.00 and a one year high of $2.50. The firm’s 50 day simple moving average is $2.40 and its 200 day simple moving average is $2.56. About Nippon Sheet Glass ( Get Free Report ) Read More Receive News & Ratings for Nippon Sheet Glass Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Sheet Glass and related companies with MarketBeat.com's FREE daily email newsletter .After Trump's Project 2025 denials, he is tapping its authors and influencers for key roles

By Michelle Marchante, Miami Herald (TNS) MIAMI — As her students finished their online exam, Arlet Lara got up to make a cafe con leche . Her 16-year-old son found her on the kitchen floor. First, he called Dad in a panic. Then 911. “I had a stroke and my life made a 180-degree turn,” Lara told the Miami Herald, recalling the medical scare she experienced in May 2020 in the early months of the COVID pandemic. “The stroke affected my left side of the body,” the North Miami woman and former high school math teacher said. Lara, an avid runner and gym goer, couldn’t even walk. “It was hard,” the 50-year-old mom said. After years of rehabilitation therapy and a foot surgery, Lara can walk again. But she still struggles with moving. This summer, she became the first patient in South Florida to get an implant of a new and only FDA-approved nerve stimulation device designed to help ischemic stroke survivors regain movement in their arms and hands. This first procedure was at Jackson Memorial Hospital in Miami. Lara’s rehab was at at the Christine E. Lynn Rehabilitation Center for The Miami Project to Cure Paralysis, part of a partnership between Jackson Health System and UHealth. Every year, thousands in the United States have a stroke , with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ischemic, often caused by blood clots that obstruct blood flow to the brain. For survivors, most of whom are left with some level of disability, the Vivistim Paired VNS System, the device implanted in Lara’s chest, could be a game changer in recovery, said Dr. Robert Starke, a UHealth neurosurgeon and interventional neuroradiologist. He also serves as co-director of endovascular neurosurgery at Jackson Memorial Hospital, part of Miami-Dade’s public hospital system. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant designed to help stroke survivors regain function in their arms, goes through exercises while her therapist activates the device during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. The activation works as positive reinforcement to her muscles when she completes the exercise correctly. (Alie Skowronski/Miami Herald/TNS) Arlet Lara, the first patient in South Florida to get an FDA- approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, right, runs into her rehabilitation neurology physician Dr. Gemayaret Alvarez, before her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The implant is designed to help stroke survivors regain function in their arms. (Alie Skowronski/Miami Herald/TNS) The Vivistim Paired VNS System is a small pacemaker-like device implanted in the upper chest and neck area. Patients can go home the same day. The U.S. Food and Drug Administration approved the stroke rehabilitation system in 2021 to be used alongside post-ischemic stroke rehabilitation therapy to treat moderate to severe mobility issues in hands and arms. Lara’s occupational therapist can activate the device during rehabilitation sessions to electrically stimulate the vagus nerve, which runs from the brain down to the abdomen and regulates various parts of the body’s nervous system. The electrical stimulation rewires the brain to improve a stroke survivor’s ability to move their arms and hands. Lara also has a magnet she can use to activate the device when she wants to practice at home. Her therapy consists of repetitive tasks, including coloring, pinching cubes and grabbing and releasing cylindrical shapes. After several weeks of rehabilitation therapy with the device, Lara has seen improvement. “Little by little, I’m noticing that my hand is getting stronger. I am already able to brush my teeth with the left hand,” she told the Miami Herald in September. Since then, Lara has finished the initial six-week Vivitism therapy program, and is continuing to use the device in her rehabilitation therapy. She continues to improve and can now eat better with her left hand and can brush her hair with less difficulty, according to her occupational therapist, Neil Batungbakal. Lara learned about the device through an online group for stroke survivors and contacted the company to inquire. She then connected them with her Jackson medical team. Now a year later, the device is available to Jackson patients. So far, four patients have received the implant at Jackson. Starke sees the device as an opportunity to help bring survivors one step closer to regaining full mobility. Strokes are a leading cause of disability worldwide. While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when paired with rehabilitation therapy, could change that. Jackson Health said results of a clinical trial published in the peer-reviewed medical journal The Lancet in 2021 showed that the device, “when paired with high-repetition, task-specific occupational or physical therapy, helps generate two to three times more hand and arm function for stroke survivors than rehabilitation therapy alone.” The device has even shown to benefit patients 20 years from their original stroke, according to Starke. “So now a lot of these patients that had strokes 10-15 years ago that thought that they would never be able to use their arm in any sort of real functional way are now able to have a real meaningful function, which is pretty tremendous,” Starke said. Vivistim’s vagus-nerve stimulation technology was developed by researchers at the University of Texas at Dallas’ Texas Biomedical Device Center and is being sold commercially by Austin-based MicroTransponder, a company started by university graduates. Similar devices are used to treat epilepsy and depression . For Lara, the device is a new tool to help her recovery journey. “Everything becomes a challenge so we are working with small things every day because I want to get back as many functions as possible,” Lara said. Patients interested in Vivistim should speak with their doctor to check their eligibility. The FDA said patients should make sure to discuss any prior medical history, including concurrent forms of brain stimulation, current diathermy treatment, previous brain surgery, depression, respiratory diseases and disorders such as asthma, and cardiac abnormalities. “Adverse events included but were not limited to dysphonia (difficulty speaking), bruising, falling, general hoarseness, general pain, hoarseness after surgery, low mood, muscle pain, fracture, headache, rash, dizziness, throat irritation, urinary tract infection and fatigue,” the FDA said. MicroTransponder says the device is “covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis.” To learn more about the device, visit vivistim.com. ©2024 Miami Herald. Visit at miamiherald.com. Distributed by Tribune Content Agency, LLC.SINGAPORE: Xi Jinping and Donald Trump's bromance could be rekindled in 2025 , if both sides play their cards right. This is positive and would help create the right environment for an improvement in ties between the two superpowers, but timing and tone are everything. The economic rivals will need to give and take to prevent the relationship from getting worse. There are potential signs of a rapprochement. It was a smart move by the US president-elect to invite Xi to his inauguration in January (the Chinese leader reportedly turned it down), but future attempts need to be more than just empty gestures to make a real difference. A face-to-face meeting, sooner rather than later, is essential to set the tone of the bilateral relationship over the next four years. The alternative is continued misunderstanding, which in the worst-case scenario, could lead to actual conflict. There is precedence for this. During Trump’s first term, he regularly talked up his warm ties with Xi, going so far as to say the two leaders “love each other”. Still, that didn’t stop the then-US president from imposing harsh trade tariffs on Beijing, the start of a prominent shift in US-China relations that solidified during the Biden administration. CHINA'S CHALLENGES Next year looks set to be another challenging one for Xi. China is facing a continued loss of investor confidence, a deepening real estate crisis, ballooning local government debt, a volatile stock market, deflationary pressures, and increasing popular discontent. Improving relations with the US could go a long way towards lifting sentiment at home. In order to do that, Xi will have to find some common ground with Trump. That won’t be easy. During his campaign, Trump floated revoking Beijing’s most-favoured-nation status. He also said he would slap tariffs of as much as 60 per cent on all imports from China. Bloomberg Economics says this would manifest itself in three waves of tariff hikes, starting in summer 2025, with levies on China ultimately tripling by the end of 2026. Further analysis indicates China could say goodbye to 83 per cent of its sales to the US, a huge pressure on exports which are already suffering. A Trump presidency is forcing China out of its economic policy inertia. Last week’s annual economic work conference made “boosting consumption” its top priority, with the readout calling for specific measures such as increasing government-sponsored pension and medical insurance payments. The president-elect is using tariffs as leverage. He has a potential cabinet lined up with China hawks who could revive hardline trade policies. The Chinese leader is well aware of the impending threats, so he has been making an effort. After Trump’s election, he reached out with a congratulatory message stating that “both China and the United States stand to gain from cooperation and lose from confrontation”. But this relationship has to work on Beijing’s terms, too. CHANNELS FOR COMMUNICATION It is clear what Xi’s boundaries are. During last month’s Asia-Pacific Economic Cooperation meeting with President Joe Biden, he emphasised the “four red lines” that Washington should not cross: Taiwan, democracy and human rights, the Chinese political system, and Beijing’s right to development. The declaration was a clear warning to the Trump administration that breaching them could further heighten tensions. Some form of formal communication channels should be established before any further tariffs are imposed by Washington, to prevent a cycle of retaliation from Beijing. If that doesn’t happen, it will take months or even longer to get both sides back to the negotiating table. There is a potential template that currently exists for talks: The strategic channel between National Security Advisor Jake Sullivan and Foreign Minister Wang Yi that has helped stabilise relations since 2022. There have been rare moments of coming together. Most recently, the countries signed an agreement extending bilateral government-to-government scientific cooperation for another five years. It allows for science and tech cooperation but minimises the risk to national security, and keeps the development of critical and emerging technologies off-limits to Beijing. On China’s side, rebuilding relations will depend on its perception of Trump’s new national security team and whether there will be any room to create back channels for future negotiations. The new Washington administration could adopt a more transactional approach that could leave Taiwan’s security as a bargaining chip. Last week’s naval exercises around the Taiwan Strait were among Beijing’s largest in 30 years, according to Taiwanese officials – a reminder that China sees the self-ruled island as its own, and it wants the US to stay out of its way. The most we can hope for is a renewed cordiality between Trump and Xi. The nature of the US-China relationship will be defined by strategic competition. Preventing further deterioration is crucial.Equities researchers at StockNews.com initiated coverage on shares of Surmodics ( NASDAQ:SRDX – Get Free Report ) in a report issued on Saturday. The firm set a “hold” rating on the stock. Separately, Needham & Company LLC restated a “hold” rating on shares of Surmodics in a research report on Thursday, November 7th. Five equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $50.00. Check Out Our Latest Research Report on Surmodics Surmodics Price Performance Surmodics ( NASDAQ:SRDX – Get Free Report ) last posted its earnings results on Wednesday, November 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.14. The business had revenue of $33.23 million for the quarter, compared to analysts’ expectations of $30.69 million. Surmodics had a negative net margin of 9.15% and a negative return on equity of 3.77%. As a group, sell-side analysts predict that Surmodics will post 0.17 earnings per share for the current fiscal year. Institutional Trading of Surmodics Several institutional investors and hedge funds have recently made changes to their positions in the stock. SG Americas Securities LLC grew its position in Surmodics by 14.7% in the first quarter. SG Americas Securities LLC now owns 5,138 shares of the company’s stock worth $151,000 after acquiring an additional 660 shares in the last quarter. Vanguard Group Inc. raised its position in Surmodics by 0.7% during the first quarter. Vanguard Group Inc. now owns 865,214 shares of the company’s stock valued at $25,385,000 after purchasing an additional 5,927 shares in the last quarter. Lazard Asset Management LLC lifted its stake in Surmodics by 13.4% during the first quarter. Lazard Asset Management LLC now owns 5,679 shares of the company’s stock worth $166,000 after purchasing an additional 673 shares during the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Surmodics by 4,722.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 68,429 shares of the company’s stock worth $2,877,000 after purchasing an additional 67,010 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Surmodics by 16.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 58,610 shares of the company’s stock valued at $2,464,000 after purchasing an additional 8,220 shares during the last quarter. Hedge funds and other institutional investors own 96.63% of the company’s stock. Surmodics Company Profile ( Get Free Report ) Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). Read More Receive News & Ratings for Surmodics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surmodics and related companies with MarketBeat.com's FREE daily email newsletter .

DONALD Trump yesterday declared trade war on US neighbours, sending the dollar soaring. He revealed plans for 25 per cent tariffs on Mexican and Canadian goods. The President-elect said he would implement the policy from day one until the countries stop the flow of illegal drugs and migrants into America. The dollar rose against the Mexican peso and Canadian dollar as Mr Trump also vowed to levy an extra ten per cent on imports from China when he returns to the White House . His announcement on his Truth Social site saw Britain and Europe spared of his pledge to protect US manufacturing. But fearful British ministers were reportedly drawing up retaliatory levies on the import of Jack Daniel’s whiskey, Levi’s jeans and Harley-Davidson bikes. Read more on Donald Trump Trade Secretary Jonathan Reynolds insisted Britain is prepared for “all eventualities”. He said: “Yes, it’s true to say if any country imposed tariffs on UK companies exporting, it would hurt our companies.” The FTSE 100 slumped yesterday — with the London index falling 33.07 points to 8,258.61. The Mexican peso dropped to its weakest since 2022 while the Canadian dollar hit a four-year low against the US dollar. Most read in The Sun But about the tariffs, bank ING warned: “Our research shows they could cost US consumers up to $2,400 per capita annually.” U.S. tariffs on Mexico and Canada may force Brit firms such as drinks giant Diageo to raise prices to recover costs. Diageo, owner of tequila brands Don Julio and George Clooney’s Casamigos — both made in Mexico — lost almost £1billion of value yesterday. Whisky brand Crown Royal, made in Canada, accounts for a fifth of Diageo’s US sales. Price rises for US consumers could also trigger a ripple effect of hikes for Brits.Byfield scores in 200th career game as Kings hold off Kraken for 2-1 win

The last two weeks of 2024 are chock full of entertaining opportunities. From Christmas and Hanukkah to Kwanza and New Year's, chances are you're going to see more people in your home in the next few days than any other time this year. I hosted Christmas dinner and with it came the reminder that I am not a clean and tidy entertainer. Eggnog was spilled, my path through the house was easily trackable as I carried a ham-laden platter, mud was tracked in from seemingly everywhere. Thankfully I had a secret weapon in my cleaning arsenal that made all of these things nothing more than a few seconds of inconvenience. The Dyson WashG1 is a powered mop that completely eliminates the need to vacuum before you clean up your floor. What Is It? Surprisingly simple in operation, the WashG1 is an upright powered mop that uses a pair of counter-rotating mop rollers that clean themselves as they remove spills and hard debris from your floor in one pass. Surprisingly, for a company that prides itself on vacuum suction, the WashG1 relies on agitation from the rollers rather than suction to clean your floors. The 64,000 filament microfiber mops are scraped clean as they run, sluicing off debris and dirty water, ensuring the mop touching the floor is perpetually clean. The company tested a large number of real spills (far beyond the industry standard of dried mustard, tartar sauce, and coffee) on a black floor using UV light to ensure the WashG1 was legitimately passing every test. The best part of using the Wash GI is that you don't have to clean your floor before you clean your floor. Hard debris (like the nut shells left all over your kitchen floor by that one uncle that insists nutcrackers are functional, not decorative) is captured in a pull-out tray in-between the two rollers. At the end of a cleaning session, all you have to do is slide it out and dump the gunk that's been captured by the filter. Meanwhile, dirty water is separated out. Just unclip the central water module, unscrew the dirty water reservoir, and dump it out. The WashG1 uses a small motor to create negative pressure to siphon dirty water up from the tray. The smaller motor translates to a long run time on a single charge. The water tanks are prominent and easily visible when operating so you don't have to guess if you need more clean water or to empty the dirty water. How Well Does It Work? The WashG1 feels awkward in hand at first, but once you start the mop rollers, it easily glides across the floor, mopping up the water that it puts down. The amount of water is controllable via a handy button and the full-color LCD screen keeps you informed on what the machine is doing or needs. The head swivels easily into just about any spot. The handle swings horizontally with the brush head so it's a cinch to clean under furniture. I also really appreciate that you can lock the mop in an upright position. It makes it much easier when you have to stop mid-task to take care of something (as opposed to having to prop the handle and hope it doesn't fall). When you're done cleaning, there's no need to disassemble the mop rollers, Just run a self-cleaning cycle. I was concerned that there would be mildew growth (a problem I've encountered with powered mops, that don't have drying bases) but those fears were unfounded. Whenever I needed the WashG1, it was ready to grab and press into action. Not having to vacuum beforehand does mean that the debris tray will fill up. You'll want to make sure you clean it out every time. The mopping module pulls out easily as well for occasional cleaning. Dyson recommends you do this every third use. I find that I need to do it at least every other run because I have a lot of pet and person hair floating around my home. What's nice is that the WashG1's screen walks you through the manual cleaning process whenever you start a self-cleaning cycle. Is It Worth It? At $699 it's in line with comparable products from Tineco and Roborock. And while other companies have more gimmicks, like heated drying or heated/ozonated water, I appreciate the fact that Dyson's focused on making the WashG1 a deeply effective machine without adding on additional tech. If you have hard floors, the WashG1 is an unfussy, impressive performer that will keep your floors pristine no matter what you throw at them. Learn more on the Dyson website .

Travis Lazarczyk: UMaine football improved, but job not done

US tech giants Nvidia, Tesla emerge top US-listed stock picks for Indians in 2024; ETFs gain momentum

Deep-pocketed investors have adopted a bullish approach towards Barrick Gold GOLD , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GOLD usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Barrick Gold. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 44% leaning bullish and 33% bearish. Among these notable options, 2 are puts, totaling $95,041, and 7 are calls, amounting to $429,726. Predicted Price Range After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $30.0 for Barrick Gold, spanning the last three months. Volume & Open Interest Trends Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Barrick Gold's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Barrick Gold's whale trades within a strike price range from $5.0 to $30.0 in the last 30 days. Barrick Gold Option Activity Analysis: Last 30 Days Biggest Options Spotted: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume GOLD CALL TRADE NEUTRAL 01/16/26 $1.11 $1.09 $1.1 $20.00 $106.9K 109.2K 1.8K GOLD CALL SWEEP BULLISH 01/16/26 $1.09 $1.07 $1.09 $20.00 $93.4K 109.2K 861 GOLD CALL SWEEP BEARISH 12/18/26 $0.62 $0.61 $0.61 $30.00 $77.9K 534 1.4K GOLD CALL SWEEP BULLISH 01/16/26 $1.89 $1.84 $1.89 $17.00 $66.1K 8.0K 610 GOLD PUT TRADE BULLISH 12/18/26 $9.5 $9.35 $9.41 $25.00 $52.6K 715 101 About Barrick Gold Based in Toronto, Barrick Gold is one of the world's largest gold miners. In 2023, the firm produced nearly 4.1 million attributable ounces of gold and about 420 million pounds of copper. At year-end 2023, Barrick had about two decades of gold reserves along with significant copper reserves. After buying Randgold in 2019 and combining its Nevada mines in a joint venture with competitor Newmont later that year, it operates mines in 19 countries in the Americas, Africa, the Middle East, and Asia. The company also has growing copper exposure. Its potential Reko Diq project in Pakistan, if developed, could double copper production by the end of the decade. After a thorough review of the options trading surrounding Barrick Gold, we move to examine the company in more detail. This includes an assessment of its current market status and performance. Where Is Barrick Gold Standing Right Now? With a volume of 3,871,346, the price of GOLD is down -0.22% at $15.71. RSI indicators hint that the underlying stock may be approaching oversold. Next earnings are expected to be released in 47 days. Unusual Options Activity Detected: Smart Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access . Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Barrick Gold with Benzinga Pro for real-time alerts. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Autistic teen 'let down' by police, says sister